These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 33394183

  • 1. Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function.
    Masood A, Jacob M, Gu X, Abdel Jabar M, Benabdelkamel H, Nizami I, Li L, Dasouki M, Abdel Rahman AM.
    Metabolomics; 2021 Jan 04; 17(1):4. PubMed ID: 33394183
    [Abstract] [Full Text] [Related]

  • 2. Dried Blood Spot-Based Metabolomic Profiling in Adults with Cystic Fibrosis.
    Al-Qahtani W, Abdel Jabar M, Masood A, Jacob M, Nizami I, Dasouki M, Abdel Rahman AM.
    J Proteome Res; 2020 Jun 05; 19(6):2346-2357. PubMed ID: 32312052
    [Abstract] [Full Text] [Related]

  • 3. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
    Joseloff E, Sha W, Bell SC, Wetmore DR, Lawton KA, Milburn MV, Ryals JA, Guo L, Muhlebach MS.
    Pediatr Pulmonol; 2014 May 05; 49(5):463-72. PubMed ID: 23847148
    [Abstract] [Full Text] [Related]

  • 4. Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
    DiBattista A, McIntosh N, Lamoureux M, Al-Dirbashi OY, Chakraborty P, Britz-McKibbin P.
    J Proteome Res; 2019 Mar 01; 18(3):841-854. PubMed ID: 30507207
    [Abstract] [Full Text] [Related]

  • 5. Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study.
    Zang X, Monge ME, McCarty NA, Stecenko AA, Fernández FM.
    J Proteome Res; 2017 Feb 03; 16(2):550-558. PubMed ID: 28152602
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
    Zang X, Pérez JJ, Jones CM, Monge ME, McCarty NA, Stecenko AA, Fernández FM.
    J Am Soc Mass Spectrom; 2017 Aug 03; 28(8):1489-1496. PubMed ID: 28364225
    [Abstract] [Full Text] [Related]

  • 7. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC, de Lima Marson FA, Ribeiro JD, Paschoal IA, Pereira MC, Ribeiro AF, Bertuzzo CS.
    Gene; 2014 May 01; 540(2):183-90. PubMed ID: 24583165
    [Abstract] [Full Text] [Related]

  • 8. Metabolomic responses to lumacaftor/ivacaftor in cystic fibrosis.
    Kopp BT, McCulloch S, Shrestha CL, Zhang S, Sarzynski L, Woodley FW, Hayes D.
    Pediatr Pulmonol; 2018 May 01; 53(5):583-591. PubMed ID: 29461009
    [Abstract] [Full Text] [Related]

  • 9. Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.
    Esther CR, Coakley RD, Henderson AG, Zhou YH, Wright FA, Boucher RC.
    Chest; 2015 Aug 01; 148(2):507-515. PubMed ID: 25611918
    [Abstract] [Full Text] [Related]

  • 10. Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis.
    Benabdelkamel H, Alamri H, Okla M, Masood A, Abdel Jabar M, Alanazi IO, Alfadda AA, Nizami I, Dasouki M, Abdel Rahman AM.
    Int J Mol Sci; 2020 Oct 08; 21(19):. PubMed ID: 33050003
    [Abstract] [Full Text] [Related]

  • 11. Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity.
    Sagel SD, Wagner BD, Ziady A, Kelley T, Clancy JP, Narvaez-Rivas M, Pilewski J, Joseloff E, Sha W, Zelnick L, Setchell KDR, Heltshe SL, Muhlebach MS.
    J Cyst Fibros; 2020 Jul 08; 19(4):632-640. PubMed ID: 31870630
    [Abstract] [Full Text] [Related]

  • 12. Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.
    Laguna TA, Reilly CS, Williams CB, Welchlin C, Wendt CH.
    Pediatr Pulmonol; 2015 Sep 08; 50(9):869-77. PubMed ID: 26115542
    [Abstract] [Full Text] [Related]

  • 13. Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.
    Wetmore DR, Joseloff E, Pilewski J, Lee DP, Lawton KA, Mitchell MW, Milburn MV, Ryals JA, Guo L.
    J Biol Chem; 2010 Oct 01; 285(40):30516-22. PubMed ID: 20675369
    [Abstract] [Full Text] [Related]

  • 14. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
    Magalhães M, Rivals I, Claustres M, Varilh J, Thomasset M, Bergougnoux A, Mely L, Leroy S, Corvol H, Guillot L, Murris M, Beyne E, Caimmi D, Vachier I, Chiron R, De Sario A.
    Clin Epigenetics; 2017 Oct 01; 9():19. PubMed ID: 28289476
    [Abstract] [Full Text] [Related]

  • 15. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.
    Alvarez JA, Chong EY, Walker DI, Chandler JD, Michalski ES, Grossmann RE, Uppal K, Li S, Frediani JK, Tirouvanziam R, Tran VT, Tangpricha V, Jones DP, Ziegler TR.
    Metabolism; 2017 May 01; 70():31-41. PubMed ID: 28403943
    [Abstract] [Full Text] [Related]

  • 16. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
    Nagy B, Nagy B, Fila L, Clarke LA, Gönczy F, Bede O, Nagy D, Újhelyi R, Szabó Á, Anghelyi A, Major M, Bene Z, Fejes Z, Antal-Szalmás P, Bhattoa HP, Balla G, Kappelmayer J, Amaral MD, Macek M, Balogh I.
    Chest; 2016 Sep 01; 150(3):661-72. PubMed ID: 27105680
    [Abstract] [Full Text] [Related]

  • 17. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B, Amato A, Majo F, Ferrari G, Quattrucci S, Minicucci L, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M, Gruppo di lavoro RIFC.
    Epidemiol Prev; 2019 Sep 01; 43(4S1):1-36. PubMed ID: 31370382
    [Abstract] [Full Text] [Related]

  • 18. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M, Gruppo di lavoro RIFC.
    Epidemiol Prev; 2021 Sep 01; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [Abstract] [Full Text] [Related]

  • 19. Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation.
    Muhlebach MS, Sha W, MacIntosh B, Kelley TJ, Muenzer J.
    Metabol Open; 2019 Sep 01; 3():100010. PubMed ID: 32812947
    [Abstract] [Full Text] [Related]

  • 20. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K, Taylor-Cousar JL.
    Ther Adv Respir Dis; 2015 Dec 01; 9(6):313-26. PubMed ID: 26416827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.